Showing 1 - 10 of 21,170
, the World Health Organization’s declaration of a pandemic would trigger a global procurement and distribution scheme for … innovation, as they allow supracompetitive pricing. In times of global public health crises, however, the ordinary principles of … global, centralized scheme to provide access to vaccines during pandemics. In many ways our proposal mirrors some of the WHO …
Persistent link: https://www.econbiz.de/10013231712
Persistent link: https://www.econbiz.de/10013545964
In the context of a health emergency like the COVID-19 pandemic, the global availability of and access to vaccines are …
Persistent link: https://www.econbiz.de/10013194326
Various non-pharmaceutical interventions (NPIs) were adopted by countries worldwide to contain the transmission of COVID-19. But their implementation raises a debate on the effectiveness of these mitigation measures. Studying 13 types of NPIs with the daily data of 185 countries from January to...
Persistent link: https://www.econbiz.de/10014362399
Persistent link: https://www.econbiz.de/10012433673
Persistent link: https://www.econbiz.de/10013275814
I use the data on the COVID-19 pandemic maintained by Our Word in Data to estimate a nonstationary dynamic panel exhibiting the dynamics of confirmed deaths, infections and vaccinations per million population in the European Union countries in the period of January–July 2021. Having the data...
Persistent link: https://www.econbiz.de/10013355090
The purpose of this multiple case study is to explore the internationalization processes, patterns, and behaviours of BioTech firms producing a COVID-19 vaccine using the Biotechnology international new ventures (BioTech INVs) model as a conceptual framework. The sample consists of eight BioTech...
Persistent link: https://www.econbiz.de/10013223697
vaccine using the Born Global internationalization model as a conceptual framework. The research methodology that has been …
Persistent link: https://www.econbiz.de/10013248074
advanced economies. We show that the global GDP loss of not inoculating all the countries, relative to a counterfactual of … global vaccinations, can be higher than the cost of manufacturing and distributing vaccines globally. We use an economic … costs for 65 countries and 35 sectors. Our estimates suggest that up to 49 percent of the global economic costs of the …
Persistent link: https://www.econbiz.de/10012548218